These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil. Bauernfeind A, Jungwirth R. Infection; 1991; 19(5):353-62. PubMed ID: 1800377 [Abstract] [Full Text] [Related]
3. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients. Fulton B, Perry CM. Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640 [Abstract] [Full Text] [Related]
14. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group. Asmar BI, Dajani AS, Del Beccaro MA, Mendelman PM. Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000 [Abstract] [Full Text] [Related]
16. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Perry CM, Scott LJ. Drugs; 2004 Apr; 64(13):1433-64. PubMed ID: 15212560 [Abstract] [Full Text] [Related]
18. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients. MacLoughlin GJ, Barreto DG, de la Torre C, Pinetta EA, del Castillo F, Palma L. J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113 [Abstract] [Full Text] [Related]
19. A critical review of the new oral cephalosporins. Considerations and place in therapy. Rodman DP, McKnight JT, Anderson RL. Arch Fam Med; 1994 Nov; 3(11):975-80. PubMed ID: 7804480 [Abstract] [Full Text] [Related]
20. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis]. Wallrauch-Schwarz C, Milatovic D, Braveny I. Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645 [Abstract] [Full Text] [Related] Page: [Next] [New Search]